The following table shows the list of Horizon 2020 projects developed by "NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 232˙500.00 | 2015-07-01 | 726 |
2 | HARMONY | H2020-EU.3.1.7. | participant | 400˙000.00 | 2017-01-01 | 965 |
3 | ROADMAP | H2020-EU.3.1.7. | participant | 292˙500.00 | 2016-11-01 | 891 |
4 | DO-IT | H2020-EU.3.1.7. | participant | 298˙788.00 | 2017-02-01 | 1063 |
5 | IMPACT HTA | H2020-EU.3.1.5. | participant | 346˙118.00 | 2018-01-01 | 856 |
6 | GetReal Initiative | H2020-EU.3.1.7. | participant | 220˙000.00 | 2018-06-01 | 330 |
7 | HTx | H2020-EU.3.1.6. | participant | 808˙250.00 | 2019-01-01 | 304 |
8 | EHDEN | H2020-EU.3.1.7. | participant | 610˙000.00 | 2018-11-01 | 370 |
9 | VALUE-Dx | H2020-EU.3.1.7. | participant | 137˙793.00 | 2019-04-01 | 430 |
10 | NEURONET | H2020-EU.3.1.7. | participant | 303˙250.00 | 2019-03-01 | 314 |
11 | ERA4TB | H2020-EU.3.1.7. | participant | 293˙500.00 | 2020-01-01 | 414 |
12 | CoroPrevention | H2020-EU.3.1.6. | participant | 103˙750.00 | 2020-01-01 | 419 |
totale | 4˙046˙449.00 |
This organization collaborated with partners in 26 countries.
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project HARMONY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LYSA | THE LYMPHOMA STUDY ASSOCIATION (REC) |
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | FR | GRAALL | GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (REC) |
participant | DE | GPOH | GPOH GEMEINNUTZIGE GMBH (REC) |
participant | IT | FISMonlus | FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS (REC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | DE | ERIC | EUROPEAN RESEARCH INITIATIVE ON CLL EV (REC) |
participant | NL | EHA | EUROPEAN HEMATOLOGY ASSOCIATION (OTH) |
participant | BE | EAPM | EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL (REC) |
participant | DE | ELN Foundation | STIFTUNG ELN FOUNDATION (OTH) |
participant | IT | Menarini | MENARINI RICERCHE SPA (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | ES | IJC | FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS (REC) |
coordinator | ES | IECSCYL | FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON (REC) |
participant | FI | MS | MEDISAPIENS OY (PRC) |
participant | FR | GFM | GROUPE FRANCOPHONE DES MYELODYSPLASIES (REC) |
participant | UK | Takeda EU | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | LeukaNET | LEUKANET EV (OTH) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | DE | MLL | MLL MUNCHNER LEUKAMIELABOR GMBH (PRC) |
participant | NL | EBMT | EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (OTH) |
participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
participant | ES | HULAFE | FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (REC) |
participant | ES | GMV | GMV SOLUCIONES GLOBALES INTERNET SAU (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | UK | BHT | BARTS AND THE LONDON NHS TRUST (REC) |
participant | DE | BfArM | BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE (PUB) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | AEMPS | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (PUB) |
participant | ES | UNAV | UNIVERSIDAD DE NAVARRA (HES) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | BE | VIB | VIB (REC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | URTV | UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA (HES) |
participant | DE | UDUS | HEINRICH-HEINE-UNIVERSITAET DUESSELDORF (HES) |
participant | IT | UNITO | UNIVERSITA DEGLI STUDI DI TORINO (HES) |
participant | CZ | MU | Masarykova univerzita (HES) |
participant | DE | UULM | UNIVERSITAET ULM (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | UK | UoY | UNIVERSITY OF YORK (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | DE | IAP | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (HES) |
participant | UK | GRL | GENOME RESEARCH LIMITED (REC) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | FI | UHEL | HELSINGIN YLIOPISTO (HES) |
Within the project ROADMAP this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | CBG/MEB | AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN (PUB) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | IXICO | IXICO TECHNOLOGIES LIMITED (PRC) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | CH | AC Immune | AC IMMUNE SA (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | ES | IDIAP Jordi Gol | FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA (REC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | FR | CHUB | CHU HOPITAUX DE BORDEAUX (HES) |
participant | UK | GE | GE HEALTHCARE LIMITED (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
participant | SE | UGOT | GOETEBORGS UNIVERSITET (HES) |
coordinator | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | DK | AU | AARHUS UNIVERSITET (HES) |
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project IMPACT HTA this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | PL | AOTMiT | AGENCJA OCENY TECHNOLOGII MEDYCZNYCH I TARYFIKACJI (PUB) |
participant | FR | PSE | ECOLE D'ECONOMIE DE PARIS (HES) |
participant | FR | APHP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | IT | UBIEFE | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | ES | UCLM | UNIVERSIDAD DE CASTILLA - LA MANCHA (HES) |
participant | DE | UNIBI | UNIVERSITAET BIELEFELD (HES) |
participant | ES | EASP | ESCUELA ANDALUZA DE SALUD PUBLICA SA (PRC) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | IT | UCSC | UNIVERSITA CATTOLICA DEL SACRO CUORE (HES) |
participant | SI | IER | INSTITUT ZA EKONOMSKA RAZISKOVANJA (REC) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | PT | IST | INSTITUTO SUPERIOR TECNICO (HES) |
Within the project GetReal Initiative this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
participant | BE | VT | VITAL TRANSFORMATION (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | FR | LA-SER | L.A SANTE, EPIDEMIOLOGIE, EVALUATION ET RECHERCHE L.A.S.E.R. (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
Within the project HTx this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | HU | SRI | SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG (PRC) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | FI | UOULU | OULUN YLIOPISTO (HES) |
participant | BG | MUS | MEDICAL UNIVERSITY SOFIA (HES) |
participant | ES | UPM | UNIVERSIDAD POLITECNICA DE MADRID (HES) |
participant | NL | UMaastricht | UNIVERSITEIT MAASTRICHT (HES) |
participant | CH | UNIBE | UNIVERSITAET BERN (HES) |
participant | UK | YORK | UNIVERSITY OF YORK (HES) |
coordinator | NL | UUtrecht | UNIVERSITEIT UTRECHT (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
Within the project EHDEN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CZ | Odysseus | ODYSSEUS DATA SERVICES SRO (PRC) |
participant | UK | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | NL | THE HYVE | THE HYVE BV (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | PT | UAVR | UNIVERSIDADE DE AVEIRO (HES) |
participant | EE | TARTU | TARTU ULIKOOL (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project VALUE-Dx this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | Bio-Rad | BIO-RAD (PRC) |
participant | CH | BD | BD SWITZERLAND SARL (PRC) |
participant | IE | Alere | ALERE INTERNATIONAL LIMITED (PRC) |
participant | ES | Accelerate | ACCELERATE DIAGNOSTICS SL (PRC) |
participant | AT | GÖG | GESUNDHEIT OSTERREICH GMBH (PRC) |
participant | UK | BERRY | BERRY CONSULTANTS LLP (PRC) |
participant | FR | Bioaster | BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE (REC) |
participant | CH | ESCMID | EUROPEAN SOCIETY CLINICAL MICROBIOLOGY INFECTIOUS DISEASES (EUROPAISCHE GESELLSCHAFT FUR KLINISCHE MIKROBIOLOGIE INFEKTIONSKRANKHEITEN) (OTH) |
participant | IL | RAMBAM | THE HEALTH CORPORATION - RAMBAM (REC) |
participant | FR | bMx | BIOMERIEUX SA (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | ERS | EUROPEAN RESPIRATORY SOCIETY (OTH) |
participant | ES | UNIRIOJA | UNIVERSIDAD DE LA RIOJA (HES) |
participant | US | BU | THE TRUSTEES OF BOSTON UNIVERSITY (HES) |
participant | IT | PENTA | FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS (REC) |
participant | NL | ZonMw | ZORGONDERZOEK NEDERLAND ZON (REC) |
participant | CH | FIND | FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS (OTH) |
participant | IT | UNIVR | UNIVERSITA DEGLI STUDI DI VERONA (HES) |
coordinator | BE | UANTWERPEN | UNIVERSITEIT ANTWERPEN (HES) |
participant | UK | Wellcome | THE WELLCOME TRUST LIMITED (PRC) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project NEURONET this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | PARKINSON'S UK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
coordinator | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
Within the project ERA4TB this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | BMGF | BILL & MELINDA GATES FOUNDATION (REC) |
participant | IE | C-Path | CRITICAL PATH INSTITUTE, LIMITED (PRC) |
participant | BE | SCI | SCIENSANO (REC) |
participant | NL | QPS | QPS NETHERLANDS BV (PRC) |
participant | CH | iM4TB | FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB) (OTH) |
participant | DK | GRIT | GRITSYSTEMS AS (PRC) |
participant | FR | Bioaster | BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE (REC) |
participant | FR | IBT | IMABIOTECH SAS (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | DH | Department of Health (REC) |
participant | US | TBA | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION (REC) |
participant | ES | GSK | GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL (PRC) |
participant | DE | EVT | EVOTEC INTERNATIONAL GMBH (PRC) |
participant | BE | Janssen | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | SERMAS | SERVICIO MADRILENO DE SALUD (PUB) |
participant | FR | IPL | INSTITUT PASTEUR DE LILLE FONDATION (REC) |
participant | DE | FZB | FORSCHUNGSZENTRUM BORSTEL (REC) |
participant | LV | IOS | LATVIJAS ORGANISKAS SINTEZES INSTITUTS (REC) |
participant | DE | UHC | KLINIKUM DER UNIVERSITAET ZU KOELN (HES) |
participant | IT | UPV | UNIVERSITA DEGLI STUDI DI PAVIA (HES) |
participant | ES | UNIZAR | UNIVERSIDAD DE ZARAGOZA (HES) |
coordinator | ES | UC3M | UNIVERSIDAD CARLOS III DE MADRID (HES) |
participant | SE | ULUND | LUNDS UNIVERSITET (HES) |
participant | CH | EPFL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (HES) |
participant | UK | UD | UNIVERSITY OF DUNDEE (HES) |
participant | IT | CNR | CONSIGLIO NAZIONALE DELLE RICERCHE (REC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
participant | FR | IP | INSTITUT PASTEUR (REC) |
participant | IT | UNIPD | UNIVERSITA DEGLI STUDI DI PADOVA (HES) |
Within the project CoroPrevention this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | SYNLAB | SYNLAB HOLDING DEUTSCHLAND GMBH (PRC) |
participant | FI | LAKKA | LAKKA TECHNOLOGIES OY (PRC) |
coordinator | FI | TAU | TAMPEREEN KORKEAKOULUSAATIO SR (HES) |
participant | FI | CRO | CROWN CRO OY (PRC) |
participant | BE | UniWeb | UNIWEB (PRC) |
participant | IT | IRCCS | IRCCS OSPEDALE POLICLINICO SAN MARTINO (REC) |
participant | FR | ESC/ SEC | SOCIETE EUROPEENNE DE CARDIOLOGIE (OTH) |
participant | ES | CNIC | CENTRO NACIONAL DE INVESTIGACIONESCARDIOVASCULARES CARLOS III (F.S.P.) (REC) |
participant | FI | HUS | HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ (REC) |
participant | FI | ZORA | ZORA BIOSCIENCES OY (PRC) |
participant | EL | BRFAA | IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON (REC) |
participant | PL | JAGU | UNIWERSYTET JAGIELLONSKI (HES) |
participant | FI | UOULU | OULUN YLIOPISTO (HES) |
participant | BE | UHASSELT | UNIVERSITEIT HASSELT (HES) |
participant | PT | FML | FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (HES) |
participant | UK | USFD | THE UNIVERSITY OF SHEFFIELD (HES) |
participant | DE | UHEI | RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |